SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001654954-17-011878
Filing Date
2017-12-27
Accepted
2017-12-27 17:08:28
Documents
1
Period of Report
2017-12-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 4  
1 PRIMARY DOCUMENT section16.xml 4 3662
  Complete submission text file 0001654954-17-011878.txt   5148
Mailing Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014 (408) 973-7884
Cellular Biomedicine Group, Inc. (Issuer) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 530 UNIVERSITY AVENUE, #17 PALO ALTO CA 94301
Business Address
Chan Andrew K (Reporting) CIK: 0001569877 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36498 | Film No.: 171276590